Immunotherapy for Recurrent Cervical Cancer Refractory to Platinum-based Chemotherapy: Multi-Center Trial

NCT05290935 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

122

Enrollment

OTHER

Sponsor class

Conditions

Recurrent Cervical Carcinoma
Persistent Advanced Cervical Carcinoma
Chemotherapy
Immune Checkpoint Inhibitors
Anti-PD-1 Antibody
Albumin-bound Paclitaxel

Interventions

DRUG: Anti-PD-1 antibody camrelizumab
DRUG: Albumin-bound paclitaxel

Sponsor

Lei Li